News Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Market Closed - Deutsche Boerse AG Other stock markets 10:00:46 2024-07-15 am EDT			5-day change	1st Jan Change
8.8 ^EUR	+5.77%		+0.46%	+88.03%

Jun. 27	Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024	CI
Apr. 05	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company	Jun. 27	EQ
Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024	Jun. 27	CI
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management	Jun. 04	EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy	May. 14	EQ
DD: APONTIS PHARMA AG: be executive GmbH, buy	May. 14	EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy	May. 13	EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy	May. 13	EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy	May. 13	EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy	May. 13	EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy	May. 13	EQ
Apontis Pharma : Earnings Call Q1/24 Presentation	May. 08	PU
APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed	May. 08	EQ
Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	Apr. 05	MT
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast	Apr. 05	EQ
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications	Apr. 05	EQ
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Transcript : Apontis Pharma AG, 2023 Earnings Call, Mar 28, 2024	Mar. 28
APONTIS PHARMA expects profitable growth again in 2024	Mar. 28	EQ
Apontis Pharma : Earnings Call 2023 Presentation	Mar. 27	PU
Transcript : Apontis Pharma AG - Special Call	Feb. 06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Summary

Filters